After a dismal 2024, CVS Health (NYSE:CVS) could be starting to turn itself around. Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on ...
The company saw big bills related to cancer, premature births and hospital prices driving up claim severity in the fourth ...
While the case will proceed, the federal court agreed in part with a UnitedHealth Group motion and dismissed some claims.
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Encompass Health (EHC – Research Report), with a ...
Truist Financial analyst David S Macdonald maintained a Hold rating on DaVita (DVA – Research Report) today. The company’s shares closed ...
Medicare Advantage beneficiaries who are suing UnitedHealth Group over allegedly wrongful denials of care that were based on ...
GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...
The Morning Briefing will not be published Monday, Feb. 17, in celebration of Presidents Day. Look for it again in your inbox Tuesday. RFK Jr. Is Sworn In To Lead HHS Amid A Backdrop Of Budget, Staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback